Literature DB >> 2170584

Vesicular changes in the myopathies of AIDS. Ultrastructural observations and their relationship to zidovudine treatment.

P K Panegyres1, J M Papadimitriou, P N Hollingsworth, J A Armstrong, B A Kakulas.   

Abstract

Six patients with AIDS and AIDS related complex (ARC) who developed neuromuscular symptoms associated with vesicular changes in muscle fibres are reported. Two patients in the advanced stages of AIDS, who did not receive zidovudine, developed proximal limb weakness and wasting: both had a necrotising myopathy with an unusual segmental vesicular change of myofibres. There were numerous vesicles 0.1 to 2 microns in diameter produced by dilatations of the sarcoplasmic reticulum in fibres depleted of myofibrils. Four patients developed a myopathy while receiving zidovudine for AIDS. One of these had an inflammatory myopathy which showed the development of vesicular change due to enlargement and electron lucency of mitochondria. The three other patients with ARC developed muscle pains or weakness and elevated serum CK while on zidovudine. These patients also showed vesicular changes due to enlargement and electron lucency of mitochondria associated with disruption of sarcomeres and the presence of cytoplasmic bodies. The muscular symptoms resolved when ziduvodine was stopped and repeat biopsy in one case revealed no abnormalities.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2170584      PMCID: PMC488165          DOI: 10.1136/jnnp.53.8.649

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  17 in total

1.  Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC.

Authors:  L J Bessen; J B Greene; E Louie; P Seitzman; H Weinberg
Journal:  N Engl J Med       Date:  1988-03-17       Impact factor: 91.245

2.  Progressive nemaline (rod) myopathy associated with HIV infection.

Authors:  M C Dalakas; G H Pezeshkpour; M Flaherty
Journal:  N Engl J Med       Date:  1987-12-17       Impact factor: 91.245

3.  Ultrastructure of skeletal muscle and peripheral nerve in experimental protein deficiency and its correlation with nerve conduction studies.

Authors:  S Roy; N Singh; M G Deo; V Ramalingaswami
Journal:  J Neurol Sci       Date:  1972-12       Impact factor: 3.181

4.  The effects of ageing and of cachexia upon skeletal muscle. A histopathological study.

Authors:  B E Tomlinson; J N Walton; J J Rebeiz
Journal:  J Neurol Sci       Date:  1969 Sep-Oct       Impact factor: 3.181

Review 5.  The foamy viruses.

Authors:  J J Hooks; C J Gibbs
Journal:  Bacteriol Rev       Date:  1975-09

Review 6.  Neurologic manifestations of AIDS.

Authors:  J C McArthur
Journal:  Medicine (Baltimore)       Date:  1987-11       Impact factor: 1.889

7.  Subacute structural myopathy associated with human immunodeficiency virus infection.

Authors:  M F Gonzales; R K Olney; Y T So; C M Greco; B A McQuinn; R G Miller; S J DeArmond
Journal:  Arch Neurol       Date:  1988-05

8.  Human immunodeficiency virus-associated myopathy: analysis of 11 patients.

Authors:  D M Simpson; A N Bender
Journal:  Ann Neurol       Date:  1988-07       Impact factor: 10.422

9.  Myopathy complicating the acquired immune deficiency syndrome.

Authors:  R Stern; J Gold; E F DiCarlo
Journal:  Muscle Nerve       Date:  1987-05       Impact factor: 3.217

Review 10.  Neuromuscular diseases associated with human immunodeficiency virus infection.

Authors:  M C Dalakas; G H Pezeshkpour
Journal:  Ann Neurol       Date:  1988       Impact factor: 10.422

View more
  6 in total

1.  Correlation of neuromuscular pathology in acquired immune deficiency syndrome patients with cytomegalovirus infection and zidovudine treatment.

Authors:  M E Cornford; H W Ho; H V Vinters
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

2.  Effect of zidovudine on preimplantation murine embryos.

Authors:  P Toltzis; T Mourton; T Magnuson
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

3.  Skeletal muscle involvement in human immunodeficiency virus infection.

Authors:  D Hantaï; J G Fournier; R Vazeux; H Collin; M Baudrimont; M Fardeau
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

4.  Nuclear and mitochondrial changes of muscle fibers in AIDS after treatment with high doses of zidovudine.

Authors:  J M Schröder; M Bertram; R Schnabel; U Pfaff
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

5.  Early features of zidovudine-associated myopathy: histopathological findings and clinical correlations.

Authors:  E J Cupler; M J Danon; C Jay; K Hench; M Ropka; M C Dalakas
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

6.  Muscle disease, HIV and zidovudine: the spectrum of muscle disease in HIV-infected individuals treated with zidovudine.

Authors:  H Manji; M J Harrison; J M Round; D A Jones; S Connolly; C J Fowler; I Williams; I V Weller
Journal:  J Neurol       Date:  1993-09       Impact factor: 4.849

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.